About Simbec-Orion
Simbec-Orion is a company based in Slough (United Kingdom) founded in 2014 was acquired by CBPE Capital in February 2019. Simbec-Orion offers products and services including Clinical Trial Management, Central Laboratory Services, Regulatory Affairs, and Clinical Pharmacology. Simbec-Orion operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
- Headquarter Slough, United Kingdom
- SectorsHealthcare
- Website simbecorion.com
- Social LinkedIn
- Acquired by CBPE Capital (Feb 2019)
- Legal Name Simbec-Orion Group Limited
- Date of Incorporation 02 Apr, 2013
- Jurisdiction MERTHYR TYDFIL, MID GLAMORGAN
- Annual Revenue$116.35 K (USD)-100as on Dec 31, 2019
- Net Profit$31.32 K (USD)-50as on Dec 31, 2024
- EBITDA$31.32 K (USD)-50as on Dec 31, 2024
- Investors
- Acquired byCBPE Capital
(Feb 2019)
Products & Services of Simbec-Orion
Simbec-Orion offers a comprehensive portfolio of products and services, including Clinical Trial Management, Central Laboratory Services, Regulatory Affairs, and Clinical Pharmacology.
Manages trials from Phase I to III for drug development.
Provides bioanalytical and safety testing for clinical studies.
Offers advice and documentation for regulatory compliance.
Conducts studies on drug interactions and pharmacokinetics.
Investors in Simbec-Orion
Simbec-Orion has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include CBPE Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | cbpecapital.com | - |
Investor details for Simbec-Orion
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Simbec-Orion
27 people are tracked at Simbec-Orion (18 in leadership, 9 in team).
| Name | Role | Group |
|---|---|---|
Rebecca Price-Davies | Head of IMP Management and Quality Assurance Pharmacist | Leadership |
Ana Smith | Chief People Officer | Leadership |
Charlotte Osmond | Director Of Legal Affairs And Company Secretary | Leadership |
Fabrice Chartier | Group Chief Executive Officer | Leadership |
Aize Smink | Chief Operating Officer | Leadership |
Joshua Ursell | Head of Enrolment Services, Clinical Pharmacology Unit | Leadership |
Sadiq Lutfi | Director Of Regulatory Affairs | Leadership |
Lan Wu Tann | Project Director | Leadership |
Nadine Aawar | Vice President, Operations, Clinical Pharmacology | Leadership |
Lan Tann | Senior Project Director | Leadership |
Enrique Rafalin | Senior Director, Group Head Quality Assurance | Leadership |
Kiren Sidhu | Project Director | Leadership |
Ceri Edwards | Managing Director, Clinical Pharmacology | Leadership |
Lucy Unamba | Associate Project Director | Leadership |
Christelle Grall | Project Director | Leadership |
Justine Lewand Carpenter | Project Director | Leadership |
Sandrine THERET | Project Director | Leadership |
Vito Antonio Lonoce | Clinical Operations Manager and General Manager (Italy) | Leadership |
Kimberley Wagstaff | Operations Manager | Team |
Andrea Hampden | Corporate Support Administrator | Team |
7 more people are available in the full profile.
Complete people profiles for Simbec-Orion
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Simbec-Orion
2 dated milestones of Simbec-Orion across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Simbec-Orion is founded.
- Exit Acquired by CBPE Capital.
Competitors of Simbec-Orion
Simbec-Orion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| celgene.com | 1986 | Summit, United States | $45M | 4,891 | Therapies for cancer and inflammatory diseases are developed. | |
| syneoshealth.com | 1984 | Raleigh, United States | – | 29,395 | CRO clinical development services are provided by Syneos Health. | |
| wcct.com | 1998 | Cypress, United States | $17M | 229 | Full-service CRO expertise in influenza and oncology research is offered. | |
| emmes.com | 1977 | United States | – | 195 | Outsourced contract research organization services are provided to clients. | |
| parexel.com | 1983 | Waltham, United States | – | – | Full-service clinical research organization services are provided globally by Parexel. | |
| prahs.com | 1976 | Raleigh, United States | – | 21 | Global full-service CRO services are delivered in over 80 countries. | |
| clinchoice.com | 1995 | Fort Washington, United States | $212M | 478 | CRO focused on data management, regulatory affairs and consulting services | |
| veristat.com | 1994 | Southborough, United States | – | 7 | Clinical trials and regulatory submissions are supported as a CRO. |
Detailed competitors of Simbec-Orion
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Simbec-Orion
The website of Simbec-Orion (simbecorion.com) receives about 9.8K visits a month.
- Monthly visits9.8K
▲ 48% vs previous month
Websites whose visitors overlap most with Simbec-Orion. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
researchuk.co.uk | researchuk.co.uk | 100% | – | #2,394,858 | – |
Latest news on Simbec-Orion
Complete news archive for Simbec-Orion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Simbec-Orion
10 companies that operate in the same segment as Simbec-Orion (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Simbec-Orion
Simbec-Orion was founded in 2014.
Simbec-Orion is headquartered in Slough, United Kingdom. It is registered at Slough, England, United Kingdom.
Annual revenue of Simbec-Orion is $116.35K as on Dec 31, 2019.
Simbec-Orion was established in 2014 as a contract research organization specializing in clinical trial management. Operations are centered in Slough, United Kingdom, with services encompassing trial design, execution, and regulatory compliance within the pharmaceutical and biotechnology sectors. Focus is placed on early-phase studies, including first-in-human trials, to support drug development processes for clients globally. The domain simbecorion.com is utilized for online presence.
Simbec-Orion's top competitors include Emmes, Syneos Health and ClinChoice.
Simbec-Orion offers Clinical Trial Management, Central Laboratory Services, Regulatory Affairs, and Clinical Pharmacology.
Simbec-Orion has 1 investor. Key investors include CBPE Capital.
Simbec-Orion operates through Simbec-Orion Group Limited.
Yes. Simbec-Orion was acquired by CBPE Capital in February 2019.